Loading insider details...
Latest Form 4 (Nov 12, 2026): Sale of 250,000 TEVA shares, $10.56M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 12, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale | 250,000 | $10.56M |
| Jun 8, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exercise/Conversion | 13,043 | n/a |
| Mar 9, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exercise/Conversion | 42,452 | n/a |
| Mar 6, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exercise/Conversion | 50,223 | n/a |
| Mar 5, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exercise/Conversion | 67,231 | n/a |
| Feb 18, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exercise/Conversion | 161,656 | n/a |
| Jan 29, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/Award | 620,110 | n/a |
| Jun 9, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/Award | 52,173 | n/a |
| Mar 7, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/Award | 169,811 | n/a |
| Mar 6, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exercise/Conversion | 50,223 | n/a |